CY1124195T1 - Συμπληρωματικα θεραπευτικα σκευασματα για την διαδοχικη ή ξεχωριστη χορηγηση βουτυρικου οξεος και προβιοτικων - Google Patents
Συμπληρωματικα θεραπευτικα σκευασματα για την διαδοχικη ή ξεχωριστη χορηγηση βουτυρικου οξεος και προβιοτικωνInfo
- Publication number
- CY1124195T1 CY1124195T1 CY20211100496T CY211100496T CY1124195T1 CY 1124195 T1 CY1124195 T1 CY 1124195T1 CY 20211100496 T CY20211100496 T CY 20211100496T CY 211100496 T CY211100496 T CY 211100496T CY 1124195 T1 CY1124195 T1 CY 1124195T1
- Authority
- CY
- Cyprus
- Prior art keywords
- probiotics
- butyric acid
- sequential
- separate administration
- therapeutic formulations
- Prior art date
Links
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 title abstract 4
- 239000006041 probiotic Substances 0.000 title abstract 3
- 235000018291 probiotics Nutrition 0.000 title abstract 3
- 230000000295 complement effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Στο παρόν περιγράφεται ένα κιτ, το οποίο επιτρέπει την ξεχωριστή χορήγηση βουτυρικού οξέος ή αλάτων ή εστέρων αυτού και προβιοτικών σε συνδυασμό με ξεχωριστά προβιοτικά που περιέχονται σε συγκεκριμένες κυψέλες.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A009138A ITUB20159138A1 (it) | 2015-12-22 | 2015-12-22 | Formulazioni terapeutiche integrative per la somministrazione separata, sequenziale o simultanea di acido butirrico, G.S.E probiotici e prebiotici. |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1124195T1 true CY1124195T1 (el) | 2022-05-27 |
Family
ID=55697301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100496T CY1124195T1 (el) | 2015-12-22 | 2021-06-08 | Συμπληρωματικα θεραπευτικα σκευασματα για την διαδοχικη ή ξεχωριστη χορηγηση βουτυρικου οξεος και προβιοτικων |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3187175B1 (el) |
CY (1) | CY1124195T1 (el) |
ES (1) | ES2875733T3 (el) |
IT (1) | ITUB20159138A1 (el) |
PL (1) | PL3187175T3 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL236296B1 (pl) * | 2017-08-25 | 2020-12-28 | Przed Produkcji Farmaceutycznej Hasco Lek Spolka Akcyjna | Tabletka zawierająca maślan sodu i sposób jej wytwarzania |
AT16167U1 (de) * | 2017-11-08 | 2019-03-15 | Alcus Med Gmbh | Kombinationspräparat zur diätetischen behandlung von darmbeschwerden bei reizdarmsyndrom |
PL425789A1 (pl) * | 2018-05-31 | 2019-12-02 | Passio Human Microbiome Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja priebiotyku zawierająca maślan wapnia i maślan magnezu oraz jej zastosowanie |
IT201800005908A1 (it) * | 2018-05-31 | 2019-12-01 | Compressa gastroresistente rivestita con film per il rilascio protratto di acido butirrico | |
US20190388344A1 (en) | 2018-06-22 | 2019-12-26 | Probiotech Llc | Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor |
IT201800010473A1 (it) * | 2018-11-21 | 2020-05-21 | Neilos S R L | Composizione per l’uso nella prevenzione e/o nel trattamento sintomatico della sindrome dell’intestino irritabile. |
CN111248443A (zh) * | 2020-03-10 | 2020-06-09 | 安徽大学 | 一种具有改善溃疡性结肠炎的合生元组合物及其制剂与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1236466B1 (en) * | 2001-02-28 | 2011-09-21 | Axiomedic Ltd. | Solid self-adhesive compositions for topical treatment of oral mucosal disorders |
ITMI20040187A1 (it) * | 2004-02-06 | 2004-05-06 | Cosmo Spa | Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali |
EP2012596A1 (en) * | 2006-05-03 | 2009-01-14 | Anidral S.R.L. | Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses |
IT1395328B1 (it) * | 2009-08-26 | 2012-09-14 | Alpiflor S R L | Composizione di acido butirrico miscelato con probiotici e prebiotici |
CA2805445C (en) * | 2010-07-29 | 2018-05-01 | Cosmo Technologies Ltd. | Pharmaceutical and/or dietary compositions based on short chain fatty acids |
ITMI20120131A1 (it) | 2012-02-01 | 2013-08-02 | Probiotical Spa | Batteri probiotici microincapsulati multistrato, loro produzione ed uso |
CA3101218A1 (en) * | 2013-03-14 | 2014-09-25 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
-
2015
- 2015-12-22 IT ITUB2015A009138A patent/ITUB20159138A1/it unknown
-
2016
- 2016-12-22 EP EP16206400.0A patent/EP3187175B1/en active Active
- 2016-12-22 PL PL16206400T patent/PL3187175T3/pl unknown
- 2016-12-22 ES ES16206400T patent/ES2875733T3/es active Active
-
2021
- 2021-06-08 CY CY20211100496T patent/CY1124195T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP3187175A1 (en) | 2017-07-05 |
PL3187175T3 (pl) | 2021-09-13 |
ES2875733T3 (es) | 2021-11-11 |
ITUB20159138A1 (it) | 2017-06-22 |
EP3187175B1 (en) | 2021-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124195T1 (el) | Συμπληρωματικα θεραπευτικα σκευασματα για την διαδοχικη ή ξεχωριστη χορηγηση βουτυρικου οξεος και προβιοτικων | |
CY1123142T1 (el) | Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων | |
CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
CY1124407T1 (el) | Ενωσεις αναστολεα αυτοταξινης | |
GT201600185A (es) | Moléculas de anticuerpo que se unen a lag-3 y usos de las mismas | |
CL2018001705A1 (es) | Composición farmacéutica que comprende lenalidomida amorfa y un antioxidante. | |
PE20190563A1 (es) | Genes de mini-distrofina optimizados y casetes de expresion y su uso | |
CL2017003089A1 (es) | Formas de dosificación sólidas de palbociclib | |
NI201700034A (es) | Indazoles sustituidos con benzilo como inhibidores de bub1. | |
CY1121849T1 (el) | Μεθοδοι και συνθεσεις για τη θεραπεια του καρκινου | |
CY1123963T1 (el) | Καινοτομα πολυμερικα προφαρμακα hgh | |
BR112018011133A2 (pt) | alvos terapêuticos para a correção do gene humano de distrofina por edição de gene e métodos de uso | |
CL2016002971A1 (es) | Combinación. | |
CY1122177T1 (el) | Δοτες νιτροξυλιου με βελτιωμενο θεραπευτικο δεικτη | |
CY1123290T1 (el) | Ενωσεις και μεθοδοι χρησης | |
MA40902B1 (fr) | Vaccins hpv16 thérapeutiques | |
CL2017000984A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas | |
CY1124406T1 (el) | Αζασετρονη για χρηση στη θεραπεια της απωλειας ακοης | |
MA52542A (fr) | Thérapie cellulaire adoptive | |
CO2017002400A2 (es) | Composiciones y métodos para detección de proteína smn en un sujeto | |
EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
UY36920A (es) | Formulaciones de aminoácidos de liberación modificada administradas por vía oral | |
CL2019002733A1 (es) | Formulaciones de clorhidrato del ácido 1-amino-1-ciclopropanocarboxílico. | |
BR112016020181A2 (pt) | Composições de ácido lipoico éster colina e métodos de uso. | |
AU362401S (en) | Sole for orthopedic boot |